Showa Denko Materials Co Ltd President and CEO, Hidehito Takahashi, and Kidswell Bio Corporation President and CEO, Masaharu Tani, have entered into an agreement to enable process development as well as clinical manufacturing of cell therapy products utilising the advantage of SHED (Stem cells from Human Exfoliated Deciduous teeth) which is under development by Kidswell Bio. Click to read more.